Skip to content Skip to left sidebar Skip to footer

VFC

Pfizer Vaccine for Pediatric Providers

Pfizer Vaccine for Pediatric Providers

UPDATE: Please refer to the PDPH Emergency Order Concerning COVID-19 Vaccine Information Statements 5/14 for guidance.

On May 10, the US Food and Drug Administration (FDA) expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to adolescents ages 12-15 years. Yesterday, May 12, the CDC Director adopted the CDC’s Advisory Commitee on Immunization Practices’ (ACIP) recommendation that endorsed the safety and effectiveness of Pfizer-BioNTech COVID-19 vaccine in this population. Providers may begin vaccinating 12–15-year-old patients today. This advisory contains important information regarding administering Pfizer COVID-19 Vaccine to adolescents and teenagers.

If your site has not already enrolled as a COVID-19 Vaccine Provider, you can enroll now to make sure your adolescent patients can get vaccinated!

Click here to enroll in our COVID-19 Vaccine Program!

Ordering Partial Trays of Pfizer & Adolescent Vaccination Updates

Please use this guide to order a partial tray of Pfizer.

For the week of 5/10, orders must be received by noon on Friday, 5/14. Going forward, orders must be submitted by 5 pm on Wednesday.

Only use this process to order if you’re been directed to during your COVID vaccine enrollment process.

Offering COVID-19 Vaccine

There is no longer a residency requirement for COVID-19 vaccinations. You are free to vaccinate individuals who live outside of Philadelphia city limits going forward.

PDPH does not require COVID-19 Vaccine providers to offer vaccinations to the greater public unless a site is specifically interested in vaccinating more than their patients.

If your site is interested in offering the vaccine at an off-site location, offering the vaccine to the whole family, or have questions about offering the vaccine in your community, email vaccines@phila.gov so that we can connect you with the right Philadelphia Immunization Program team member.

Co-administration

Per the ACIP meeting on 5/12, COVID-19 vaccines may be administered without regard to timing. This includes simultaneous administration of other vaccines on the same day, as well as co-administration within 14 days. We will forward the MMWR documenting this decision once its is published.

Consent

The patient or their parent and guardian must have had the opportunity to have his/her questions answered satisfactorily before the immunization is given. Written consent for immunization is not required. Implicit consent is acknowledged by the presentation for vaccination of an adolescent with their parent or guardian. There is no Vaccine Information Sheet (VIS) for this vaccine. The FACT SHEET FOR RECIPIENTS AND CAREGIVERS about the Emergency Use Authorization (EUA) Pfizer-BioNTECH COVID-19 Vaccine to Prevent Coronavirus must be shared with the intended vaccine recipient or their parent or guardian prior to immunization.

Currently in Philadelphia, individuals 16 -18 years of age may authorize his or her own immunization with the Pfizer vaccine under the EUA, without the approval or consent of another person. At this time, individuals 12 to 15 years of age must have a parent’s implicit consent for vaccination under an EUA.

Click here to download PDPH’s Emergency Order Concerning COVID-19 Vaccine Information Statements. To view the original regulations, please go to Section 4, part b of the Regulations Governing the Immunization and Treatment of Newborns, Children and Adolescents document found here.

Wastage

As COVID-19 vaccine supply becomes more available and appointments become more sporadic, PDPH is asking providers to ensure vaccination for all eligible patients, even if it means leaving some doses unused or wasted.

Right now, it is critical that providers prioritize vaccinating eligible persons who are willing to be vaccinated over wasting vaccine. Providers should vaccinate any eligible persons who wish to receive vaccine at their clinic location, even if it means puncturing a multi-dose vial and potentially wasting doses. PDPH understands that some, or all remaining doses in the vial may need to be wasted to vaccinate a person.

Please download our Vaccine Wastage Guide here. You can find additional information on vaccine wastage guidance by reading this detailed Vaccine Wastage Advisory.

Pfizer Resources

Thank you for keeping Philadelphia safe and healthy.

If you have any questions, please email vaccines@phila.gov.

Enroll Your Site as a COVID-19 Vaccine Provider!

Enroll Your Site as a COVID-19 Vaccine Provider!

Pfizer/BioNTech asked the Food and Drug Administration (FDA) on April 9th to expand the emergency approval of their COVID-19 vaccine to include its use in adolescents ages 12 to 15.

Enroll to make sure that adolescents can access COVID-19 vaccine when its available to them!  

How Do I Enroll?

To enroll as a COVID provider your site must be able to:

  • Be able to vaccinate at least 50 patients, 12 years of age and up, over a 2-week period
  • Report COVID-19 vaccination electronically within 24-hours of administration
  • Store the vaccine in monitored fridge and freezer storage units that are compliant with CDC Immunization requirements

(If your site is a VFC provider, you already meet the storage and handling and temperature reporting requirements to be a COVID-19 vaccine provider.)

To help you enroll in our COVID-19 Vaccine Provider program, we have created a Provider Agreement Guide which walks you step-by-step through the Enrollment Form. Please review the Provider Agreement Guide in its entirety before filling out the agreement form and survey. Once you have reviewed the guide, you can start filling out our Enrollment Form.

Enroll In Our COVID-19 Vaccine Program!

Have questions about the enrollment process?

Attend one of our Town Halls for VFC Providers interested in enrolling as COVID-19 Providers:

Virtual Town Hall for VFC Providers interested in enrolling as COVID-19 Providers

Dates and times:
Tuesday 5/4 at 12PM
Wednesday 5/5 at 5PM
Tuesday 5/11 at 5PM
Wednesday 5/12 at 12PM

Gotomeeting Link: https://global.gotomeeting.com/join/926918173

Meeting ID: 926 918 173

Dial In: +1 (669) 224-3412

Thank you for your continued work to keep our city safe and healthy!
If you have any questions, please email vaccines@phila.gov.

How to defrost your storage unit

How to defrost your storage unit

Storage units, especially freezers, can sometimes build up too much ice. When you need to defrost your VFC/VFAAR storage unit, TempCheck – our storage and handling coordinators – can help. TempCheck will help you safely storage the vaccine while you defrost the unit.

Use this guide to plan your defrost. Review it when you plan a defrost, and consult it during the defrost process.

If you have any questions, or if your vaccine is exposed to out-of-range temperatures during the defrost or transport process, contact TempCheck as soon as possible.

TempCheck
Adam Howsare and Alexis Bridges
TempCheck@phila.gov
215-685-6777

Plan and prepare

  1. Contact TempCheck to tell them that you are planning to defrost your unit. TempCheck will need to know when you plan to defrost, and where your back-up unit is. TempCheck will send you a backup DDL to monitor the back-up unit. Keep the packing material so you can send the DDL back to PDPH.
  2. Prepare the back-up DDL. Once you get the back-up DDL, temper the probe by putting it in your primary freezer. After 30 minutes, start up the DDL. Monitor temperatures for at least 1 hour. Alternatively, place the probe in your unit overnight and start the DDL the next morning.
  3. Move the vaccine. It’s time to move the vaccine. Leave the primary DDL in your primary unit while you defrost the primary unit.
    1. If your back-up unit is on-site: Move the vaccine and back-up DDL to your secondary unit. Note the time.
    2. If your backup unit is off-site: using the emergency transport guide, set up a hard-sided cooler for transport. Move the back-up DDL to the cooler. Place the probe in the middle. Move the vaccine into the cooler. Note the time. Transport the vaccine directly to the back-up location. Note the time the vaccine and DDL are moved into the back-up unit.

Defrosting your unit

  1. Note the time when you start defrosting your primary unit. The DDL will warm up, which will probably trigger an alarm.
  2. Allow the ice in the unit to melt.
  3. Turn the freezer back on. Wait until the DDL shows that the temperature is back in the normal range.
  4. Transfer the vaccines back into the freezer, using the same transport protocol that you used to move them to the back-up unit.

Dealing with the data

  1. Download the data from both data loggers and email it to TempCheck@phila.gov.
  2. Include the following information in the email:
    1. When you took the vaccine out of the primary unit
    2. When you put the vaccine into the back-up unit
    3. When you started defrosting the primary unit
    4. When you took the vaccine out of the back-up unit
    5. When you put the vaccine back into the defrosted primary unit
  3. Reconnect the DDL and continue temperature monitoring as usual
  4. Repackage the back-up DDL and send it back to PDPH.

ProQuad now available through VFC

ProQuad vaccine now available through the VFC program

ProQuad is now available through the Philadelphia Vaccines for Children (VFC) program. ProQuad is a combination MMR (measles, mumps, and rubella) and Varicella vaccine. This combined vaccine lets you administer more vaccines with fewer injections.

About ProQuad

The CDC’s Advisory Committee on Immunization Practices recommends ProQuad for a patient’s second dose of MMR and varicella vaccine. As a first dose, ProQuad is associated with a slightly higher risk of febrile seizure, so use separate MMR and varicella vaccines for the first dose unless a parent prefers ProQuad.

Ordering ProQuad

Order ProQuad through PhilaVax at https://vax.phila.gov the way you normally order other vaccines. Before you order ProQuad for your VFC-eligible patients, you should also stock enough privately-purchased ProQuad to treat patients who are not eligible for VFC.